Literature DB >> 19482765

Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.

Teresa Nowadzky1, Alfonso Pantoja, John R Britton.   

Abstract

OBJECTIVE: The purpose of this work was to assess a quality improvement initiative to implement a potentially better practice, bubble continuous positive airway pressure, to reduce bronchopulmonary dysplasia and improve other pulmonary outcomes among very low birth weight infants with respiratory distress syndrome.
METHODS: An initiative to implement the use of bubble continuous positive airway pressure is described that was based on the adoption of habits for change, collaborative learning, evidence-based practice, and process development. To assess the efficacy of this intervention, very low birth weight infants with respiratory distress syndrome born after implementation of bubble continuous positive airway pressure use (period 2: March 1, 2005, to October 4, 2007; N = 126) were compared with historical controls born during a previous period of ventilator use (period 1: January 1, 2003, to February 28, 2005; N = 88). Infants at both time periods were similar with respect to characteristics and aspects of perinatal care. Pulmonary outcomes compared for the 2 time periods included receipt of mechanical ventilation, duration of mechanical ventilation, pneumothoraces, and incidence of bronchopulmonary dysplasia. Nonpulmonary outcomes were also compared.
RESULTS: The use of mechanical ventilation declined during period 2. The mean duration (+ SD) of conventional ventilation during period 2 was shorter than during period 1 (3.08 + 6.17 vs 5.25 + 8.16 days), and fewer infants during period 2 required conventional ventilation for >6 days compared with those in period 1 (13.6% vs 26.3%). In regression models, the effect of period 2 persisted after controlling for other predictors of duration of conventional ventilation. There were no significant differences in other pulmonary or nonpulmonary outcomes, with the exception of mild retinopathy of prematurity (stage I or II), which was more common during period 2. The enhanced odds of retinopathy of prematurity persisted after controlling for other known predictors of this condition.
CONCLUSION: Among very low birth weight infants with respiratory distress syndrome, the use of bubble continuous positive airway pressure is a potentially better practice that may reduce the use of mechanical ventilation. Although an increase in retinopathy of prematurity was observed in our population, carefully designed randomized, controlled trials will be required to more accurately address the potential risks and benefits of this therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19482765     DOI: 10.1542/peds.2008-1279

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  Predicting death or tracheostomy placement in infants with severe bronchopulmonary dysplasia.

Authors:  K Murthy; R C Savani; J M Lagatta; I Zaniletti; R Wadhawan; W Truog; T R Grover; H Zhang; J M Asselin; D J Durand; B L Short; E K Pallotto; M A Padula; F D Dykes; K M Reber; J R Evans
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

2.  Non-invasive ventilation with bubble CPAP is feasible and improves respiratory physiology in hospitalised Malawian children with acute respiratory failure.

Authors:  J Walk; P Dinga; C Banda; T Msiska; E Chitsamba; N Chiwayula; N Lufesi; R Mlotha-Mitole; A Costello; A Phiri; T Colbourn; E D McCollum; H J Lang
Journal:  Paediatr Int Child Health       Date:  2014-11-30       Impact factor: 1.990

3.  Safety and effectiveness of bubble continuous positive airway pressure in preterm neonates with respiratory distress.

Authors:  S S Mathai; A Rajeev; K M Adhikari
Journal:  Med J Armed Forces India       Date:  2014-09-26

4.  Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi.

Authors:  Kondwani Kawaza; Heather E Machen; Jocelyn Brown; Zondiwe Mwanza; Suzanne Iniguez; Al Gest; E O'Brian Smith; Maria Oden; Rebecca R Richards-Kortum; Elizabeth Molyneux
Journal:  Malawi Med J       Date:  2016-09       Impact factor: 0.875

5.  A Randomized Trial Comparing Efficacy of Bubble and Ventilator Derived Nasal CPAP in Very Low Birth Weight Neonates with Respiratory Distress.

Authors:  Sheetal Agarwal; Arti Maria; Mahesh K Roy; Ankit Verma
Journal:  J Clin Diagn Res       Date:  2016-09-01

6.  Bubble-CPAP vs. Ventilatory-CPAP in Preterm Infants with Respiratory Distress.

Authors:  Bahareh Bahman-Bijari; Arash Malekiyan; Pedram Niknafs; Mohammad-Reza Baneshi
Journal:  Iran J Pediatr       Date:  2011-06       Impact factor: 0.364

7.  Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi.

Authors:  Kondwani Kawaza; Heather E Machen; Jocelyn Brown; Zondiwe Mwanza; Suzanne Iniguez; Al Gest; E O'Brian Smith; Maria Oden; Rebecca R Richards-Kortum; Elizabeth Molyneux
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

8.  Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention study.

Authors:  Rossano Rezzonico; Letizia M Caccamo; Valeria Manfredini; Massimo Cartabia; Nieves Sanchez; Zoraida Paredes; Patrizia Froesch; Franco Cavalli; Maurizio Bonati
Journal:  BMC Pediatr       Date:  2015-03-25       Impact factor: 2.125

9.  A high-value, low-cost bubble continuous positive airway pressure system for low-resource settings: technical assessment and initial case reports.

Authors:  Jocelyn Brown; Heather Machen; Kondwani Kawaza; Zondiwe Mwanza; Suzanne Iniguez; Hans Lang; Alfred Gest; Neil Kennedy; Robert Miros; Rebecca Richards-Kortum; Elizabeth Molyneux; Maria Oden
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Recalcitrant bubbles.

Authors:  Martin E R Shanahan; Khellil Sefiane
Journal:  Sci Rep       Date:  2014-04-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.